On February 21, Smeglutide, the “magic drug for weight loss” sweeping the world, has the effect of reducing blood sugar, reducing weight and improving cardiovascular health. It is not only popular among weight loss people, but also has become an effective means to treat diabetes. Previous evidence suggests that such drugs require sustained use to maintain their efficacy. However, a recent study found that the one-year discontinuation rate of this type of drug is as high as 40-60%, which may be related to the purpose of use, weight loss effect, and drug price. The study was published on January 31, 2025, in JAMA Network Open, a journal of the American Medical Association. The authors were from Truveta Inc, a US healthcare data platform company, and the University of Pennsylvania.
Scan code to share